Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis

Status Recruiting

Clinical Trial Summary

Walled-off necrosis (WON) is a pancreatic fluid collection, which contains necrotic tissue after four weeks of the onset of acute pancreatitis. Interventions are required to manage patients with infected WON, for which endoscopic ultrasonography (EUS)-guided drainage has become a first-line treatment modality. For patients who are refractory to EUS-guided drainage, the step-up treatment including endoscopic necrosectomy (EN) and/or additional drainage is considered to subside the infection. Recent evidence suggests that EN immediately after EUS-guided drainage may shorten treatment duration without increasing adverse events. In this randomized trial, the investigators will compare treatment duration between EN immediately after EUS-guided drainage versus the step-up approach in patients with symptomatic WON.

Clinical Trial Description

Pancreatic fluid collection is a late complication of severe acute pancreatitis. According to the revised Atlanta classification, walled-off necrosis (WON) is defined as an encapsulated collection of necrotic tissue that is observed after four weeks of the onset of acute pancreatitis. Infected WON is associated with high morbidity and mortality; therefore, an appropriate treatment, including antibiotics and drainage, is mandatory. With the development of endoscopic equipment, endoscopic ultrasonography (EUS)-guided drainage has become a first-line treatment modality for infected WON. For patients who are refractory to EUS-guided drainage, endoscopic necrosectomy (EN) is a treatment option to facilitate direct removal of infected necrotic tissue within the WON. However, due to potentially lethal adverse events of EN, such as bleeding, perforation, and peritonitis, EN is usually withheld for several days after EUS-guided drainage. This strategy is known as "the step-up approach." Recently, with the accumulated evidence supporting the safety of EN, especially with the use of a dedicated lumen-apposing metal stent, it has been reported that EN immediately after EUS-guided drainage can shorten the treatment duration without increasing adverse events. Given these lines of evidence, the investigators hypothesized that immediate EN following EUS-guided drainage of WON might shorten time to clinical success compared to the step-up approach. To examine this hypothesis, the investigators planned to conduct a multicenter randomized controlled trial comparing treatment duration between EN immediately after EUS-guided drainage versus the step-up approach in patients with symptomatic WON. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05451901
Study type	Interventional
Source	Tokyo University
Contact	Yousuke Nakai
Phone	+81-3-3815-5411
Email	ynakai-tky@umin.ac.jp
Status	Recruiting
Phase	N/A
Start date	July 29, 2022
Completion date	April 11, 2031

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03027895` - Endoscopic Ultrasound-guided Drainage of Walled Off Necrosis (WON)	N/A
Terminated	`NCT00541593` - Natural Orifice Translumenal Endoscopic Surgery (NOTES) Cystgastrostomy for the Treatment of Pancreatic Pseudocysts	N/A
Completed	`NCT03002051` - EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent	N/A
Terminated	`NCT03049215` - Lumen Apposing Metal Stents vs Lumen Apposing Metal Stent Plus Double Pigtail Stent for Endoscopic Drainage	N/A
Not yet recruiting	`NCT06133023` - WONDER-02 Trial: Plastic Stent vs. Lumen-apposing Metal Stent for Pancreatic Pseudocysts	N/A
Completed	`NCT02041793` - Laparoscopic Cystogastrostomy Versus Endoscopic Cystogastrostomy	N/A
Recruiting	`NCT06179459` - Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections
Completed	`NCT02730663` - A Study to Evaluate the Effectiveness and Safety of EUS-guided Transluminal Drainage With 'Niti-S SPAXUS Stent'	N/A
Recruiting	`NCT05716594` - Clinical Evaluation of Enteral-extended Anti-reflux Stents for Pancreatic Pseudocyst	Phase 2
Completed	`NCT00222898` - Cancer Detection in Pancreatic Cysts	N/A
Recruiting	`NCT01585662` - Prospective Random Comparing Study on EUS-guided Pseudocyst Drainage by Naso-pancreatic Tube and Stents	Phase 4
Recruiting	`NCT02845258` - Treatment of Pancreatic Pseudocysts by Endoscopic Ultrasound-guided Drainage
Completed	`NCT03797209` - Hot AXIOS System Japan Post Market Survey
Not yet recruiting	`NCT06134024` - The Role of Double Pigtail Plastic Stents During Endoscopic Transmural Drainage of Pancreatic Fluid Collections.	N/A
Completed	`NCT03147768` - Laser Tissue Welding - Distal Pancreatectomy Sealing Study	Phase 1
Not yet recruiting	`NCT03022110` - Endoscopic Ultrasound-guided Drainage of Pancreatic Pseudocysts	N/A
Active, not recruiting	`NCT03884179` - Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis — WONDER-01

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms